We are live on ! Find out more
ACM

Argyle Capital Management Portfolio holdings

AUM $347M
1-Year Est. Return 44.33%
This Fund
S&P 500
This Quarter Est. Return
-1.38%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.07%
AUM
$273M
AUM Growth
-$4.42M
Cap. Flow
+$2.99M
Cap. Flow %
1.1%
Top 10 Hldgs %
27.24%
Holding
125
New
Increased
24
Reduced
23
Closed
3

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$488K
2
GEHC icon
GE HealthCare
GEHC
+$381K
3
RTX icon
RTX Corp
RTX
+$352K
4
T icon
AT&T
T
+$342K
5
INTC icon
Intel
INTC
+$300K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$373K
2
MSFT icon
Microsoft
MSFT
+$220K
3
LH icon
Labcorp
LH
+$213K
4
MGA icon
Magna International
MGA
+$209K
5
MDC
M.D.C. Holdings, Inc.
MDC
+$202K

Sector Composition

Rank Sector Weight
1 Healthcare 22.71%
2 Technology 17.95%
3 Industrials 12.72%
4 Financials 10.58%
5 Energy 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UGI icon
101
UGI
UGI
$8.19B
$478K 0.18%
20,774
-338
-2% -$8.39K
MCO icon
102
Moody's
MCO
$81.5B
$443K 0.16%
1,400
MTB icon
103
M&T Bank
MTB
$33.3B
$423K 0.15%
3,343
-1,000
-23% -$130K
BWA icon
104
BorgWarner
BWA
$12.9B
$408K 0.15%
10,100
-1,374
-12% -$58.2K
NVS icon
105
Novartis
NVS
$265B
$405K 0.15%
3,975
NEE icon
106
NextEra Energy
NEE
$169B
$371K 0.14%
6,468
CSX icon
107
CSX Corp
CSX
$89.4B
$369K 0.14%
12,000
PEG icon
108
Public Service Enterprise Group
PEG
$35.3B
$361K 0.13%
6,350
KMT icon
109
Kennametal
KMT
$2.27B
$338K 0.12%
13,567
TEVA icon
110
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
$315K 0.12%
30,850
WRK
111
DELISTED
WestRock Company
WRK
$283K 0.1%
7,900
EMN icon
112
Eastman Chemical
EMN
$7.51B
$261K 0.1%
3,400
CNP icon
113
CenterPoint Energy
CNP
$25.2B
$247K 0.09%
9,200
WBD icon
114
Warner Bros
WBD
$70.3B
$233K 0.09%
21,444
-267
-1% -$3.33K
DEO icon
115
Diageo
DEO
$48.5B
$224K 0.08%
1,500
CR icon
116
Crane Co
CR
$11.5B
$213K 0.08%
2,400
B
117
DELISTED
Barnes Group Inc.
B
$204K 0.07%
6,000
PM icon
118
Philip Morris
PM
$302B
$204K 0.07%
2,200
NWL icon
119
Newell Brands
NWL
$2.46B
$126K 0.05%
14,000
VTRS icon
120
Viatris
VTRS
$19.4B
$125K 0.05%
12,675
-99
-0.8% -$1.03K
TRHC
121
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$105K 0.04%
10,228
OSUR icon
122
OraSure Technologies
OSUR
$242M
$59.4K 0.02%
10,025
LH icon
123
Labcorp
LH
$26.3B
-1,028
Closed -$213K
MGA icon
124
Magna International
MGA
$17.2B
-3,700
Closed -$209K
MDC
125
DELISTED
M.D.C. Holdings, Inc.
MDC
-4,320
Closed -$202K

Similar funds

Argyle Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Argyle Capital Management held 125 positions worth $273M, down 1.6% from $277M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 2.4%. Argyle Capital Management opened no new positions and exited 3, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

  • Argyle Capital Management added most to Bank of America in Q3 2023, an estimated $488K increase.
  • Argyle Capital Management's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $373K.
  • Argyle Capital Management fully exited Labcorp in Q3 2023, selling an estimated $213K.
  • Argyle Capital Management's ten largest holdings make up 27% of its $273M portfolio in Q3 2023.
  • Argyle Capital Management opened 0 new positions and closed 3 in Q3 2023.
  • Argyle Capital Management's portfolio value fell 1.6% quarter-over-quarter to $273M.

Based on Argyle Capital Management's 13F filing for Q3 2023, filed 26 Oct 2023.